Keywords: وورتایسکتین; Agomelatine; Inadequate response; Major depressive disorder; Switch; Vortioxetine;
مقالات ISI وورتایسکتین (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: وورتایسکتین; Levomilnacipran; Vilazodone; Vortioxetine; Second-generation antidepressants; Systematic review; Network meta-analysis;
Keywords: وورتایسکتین; Vortioxetine; Lu AA21004; Antidepressant; Depression; Anxiety;
Keywords: وورتایسکتین; Vortioxetine; Antidepressant; Maintenance therapy; Major depressive disorder; Tolerability;
Keywords: وورتایسکتین; Vortioxetine; Drug switching; Major depressive disorder; Drug-related side effects and adverse reactions; Comparative effectiveness research;
Keywords: وورتایسکتین; Vortioxetine (PubChem CID 9966051); Paroxetine (Pubmed CID 43815); 8-OH-DPAT (PubChem CID 1220); Flesinoxan (PubChem CID 57347); CP-94253 (PubChem CID 4029677); Ondansetron (PubChem CID 4595); Vortioxetine; 5-HT1A; 5-HT1B; 5-HT3; Male rat sexual behavior;
Keywords: وورتایسکتین; Vortioxetine; FDA; Exclusion criteria; Antidepressant efficacy trials; External validity; Antidepressants; Generalizability;
Keywords: وورتایسکتین; vortioxetine; liquid-assisted grinding; crystal structure; thermal stability; equilibrium solubility; intrinsic dissolution rate;
Keywords: وورتایسکتین; Vortioxetine; Major depressive disorder; Clinical efficacy; Meta-analysis; Drug dose-response relationship;
Keywords: وورتایسکتین; 5-HT; 5-hydroxytryptamine, serotonin; vortioxetine; 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004); LTP; long-term potentiation; SR57227; 1-(6-chloro-2-pyridinyl)-4-piperidinamine; MDD; major depressive disorder; SERT; 5-HT transporter; f
Keywords: وورتایسکتین; Vortioxetine; Meta-analysis; Efficacy; Safety; Tolerability; Generalized anxiety disorder;
Keywords: وورتایسکتین; Major depressive disorder; Cognitive function; Vortioxetine; Lu AA21004; Electrophysiology; Receptor occupancy;
Keywords: وورتایسکتین; antidepressant; health-related quality of life; major depressive disorder; patient-reported outcomes; vortioxetine;
Effects of vortioxetine and fluoxetine on the level of Brain Derived Neurotrophic Factors (BDNF) in the hippocampus of chronic unpredictable mild stress-induced depressive rats
Keywords: وورتایسکتین; Chronic unpredictable mild stress; Brain-derived neurotrophic factors; Depression; Fluoxetine; Vortioxetine;
Effects of vortioxetine on biomarkers associated with glutamatergic activity in an SSRI insensitive model of depression in female rats
Keywords: وورتایسکتین; Tryptophan; Vortioxetine; Female rat model of depression; Glutamatergic system; Corticosterone; IL-6;
Partial inhibition of catecholamine activity and enhanced responsiveness to NMDA after sustained administration of vortioxetine
Keywords: وورتایسکتین; Vortioxetine; Multimodal; Major depressive disorder; Dopamine; Norepinephrine; Glutamate;
Vortioxetina: una nueva alternativa en el trastorno depresivo mayor
Keywords: وورتایسکتین; Vortioxetina; Trastorno depresivo mayor; Antidepresivo; Cognición; Receptores de serotonina; Vortioxetine; Major depressive disorder; Antidepressant; Cognition; Serotonin receptors;
Vortioxetine: A new alternative for the treatment of major depressive disorder
Keywords: وورتایسکتین; Vortioxetine; Major depressive disorder; Antidepressant; Cognition; Serotonin receptors; Vortioxetina; Trastorno depresivo mayor; Antidepresivo; Cognición; Receptores de serotonina;
Acute effects of vortioxetine and duloxetine on resting-state functional connectivity in the awake rat
Keywords: وورتایسکتین; Vortioxetine; Duloxetine; Resting-state fMRI; Awake rat;
Efficacy and tolerability of different doses of three new antidepressants for treating major depressive disorder: A PRISMA-compliant meta-analysis
Keywords: وورتایسکتین; Major depressive disorder; Vortioxetine; Levomilnacipran; Vilazodone; Tolerability;
Novel adverse events of vortioxetine: A disproportionality analysis in USFDA adverse event reporting system database
Keywords: وورتایسکتین; Vortioxetine; Signal detection; USFDA adverse event reporting system database;
Research paperCost-utility evaluation of vortioxetine in patients with Major Depressive Disorder experiencing inadequate response to alternative antidepressants in the United Kingdom
Keywords: وورتایسکتین; Major depressive disorder; Depression; Cost-utility analysis; Inadequate response; Vortioxetine;
Acute dosing of vortioxetine strengthens event-related brain activity associated with engagement of attention and cognitive functioning in rats
Keywords: وورتایسکتین; Vortioxetine; Rat; Electrophysiology; P300 event-related potential; Neuronal oscillation; Phase-locking factor;
Crystal Structures, X-Ray Photoelectron Spectroscopy, Thermodynamic Stabilities, and Improved Solubilities of 2-Hydrochloride Salts of Vortioxetine
Keywords: وورتایسکتین; vortioxetine; X-ray photoelectron spectroscopy; crystal structure; thermal stability; equilibrium solubility; intrinsic dissolution rate;
¿En qué consiste el efecto procognitivo de los antidepresivos?
Keywords: وورتایسکتین; Atención; Funciones cognitivas; Antidepresivos; Vortioxetina; Attention; Cognitive Functions; Antidepressant drugs; Vortioxetine;
A single dose of vortioxetine, but not ketamine or fluoxetine, increases plasticity-related gene expression in the rat frontal cortex
Keywords: وورتایسکتین; Gene expression; Ketamine; Vortioxetine; Fluoxetine; Real-time qPCR; Neuroplasticity
P-glycoprotein differentially affects escitalopram, levomilnacipran, vilazodone and vortioxetine transport at the mouse blood-brain barrier in vivo
Keywords: وورتایسکتین; ABCB1; Blood-brain barrier; P-glycoprotein; Levomilnacipran; Vilazodone; Vortioxetine;
Propriétés pharmacologiques de la vortioxetine et leurs conséquences pré-cliniques
Keywords: وورتایسکتین; Vortioxetine; Dépression; Cognition; Préclinique; Antidépresseur; Multimodal; Vortioxetine; Depression; Cognition; Preclinical; Antidepressant; Multimodal;
Simultaneous quantification of vortioxetine, carvedilol and its active metabolite 4-hydroxyphenyl carvedilol in rat plasma by UPLC-MS/MS: Application to their pharmacokinetic interaction study
Keywords: وورتایسکتین; Vortioxetine; Carvedilol; 4-hydroxyphenyl carvedilol; UPLC-MS/MS; Pharmacokinetics;
Stability-indicating reversed-phase HPLC method development and characterization of impurities in vortioxetine utilizing LC-MS, IR and NMR
Keywords: وورتایسکتین; ACN; acetonitrile; ESI; electrospray ionization source; Imp-A; 1-[4-[(2,4-dimethylphenyl)thio]phenyl]-piperazine; Imp-B; 1-[2-[(2,4-dimethylphenyl)sulfinyl]phenyl]-piperazine; Imp-C; 1-(4-bromophenyl)piperazine; Imp-D; 1-(2-bromophenyl)piperazine; Imp-E;
Involvement of 5-HT7 receptors in vortioxetine's modulation of circadian rhythms and episodic memory in rodents
Keywords: وورتایسکتین; Vortioxetine; Biological rhythms; Episodic memory; 5-HT7 receptor; Behavior; Suprachiasmatic nucleus; Serotonin;
Effect of Vortioxetine vs. Escitalopram on Sexual Functioning in Adults with Well-Treated Major Depressive Disorder Experiencing SSRI-Induced Sexual Dysfunction
Keywords: وورتایسکتین; Vortioxetine; Escitalopram; Major Depressive Disorder; Treatment-Emergent Sexual Dysfunction
Associate editor: F. TaraziVortioxetine, a novel antidepressant with multimodal activity: Review of preclinical and clinical data
Keywords: وورتایسکتین; Clinical efficacy; Cognitive dysfunction; Major depressive disorder; Serotonin receptors; Vortioxetine; 5-HT; serotonin (5-hydroxytryptamine); ACh; acetylcholine; ATC; Anatomical Therapeutic Classification; CGI-I; Clinical Global Impression-Improvement; C
An UPLC-MS/MS method for the quantitation of vortioxetine in rat plasma: Application to a pharmacokinetic study
Keywords: وورتایسکتین; Vortioxetine; Rat; UPLC-MS/MS; Plasma; Pharmacokinetics;
11C-labeling and preliminary evaluation of vortioxetine as a PET radioligand
Keywords: وورتایسکتین; Cross-coupling; Vortioxetine; PET; Carbon-11; Palladium;
Vortioxetine, but not escitalopram or duloxetine, reverses memory impairment induced by central 5-HT depletion in rats: Evidence for direct 5-HT receptor modulation
Keywords: وورتایسکتین; Vortioxetine; Lu AA21004; Major depressive disorder; Cognitive impairment; Memory; 5-HT depletion;
Vortioxetine dose-dependently reverses 5-HT depletion-induced deficits in spatial working and object recognition memory: A potential role for 5-HT1A receptor agonism and 5-HT3 receptor antagonism
Keywords: وورتایسکتین; 5-HT depletion; Major depressive disorder; 5-HT1A receptor; 5-HT3 receptor; Cognitive dysfunction; Vortioxetine;
Vortioxetine (Lu AA21004), a novel multimodal antidepressant, enhances memory in rats
Keywords: وورتایسکتین; 5-HT; Serotonin; 5-HTT; 5-HT transporter; ACh; Acetylcholine; HA; Histamine; ANOVA; Analysis of Variance; ASRI; Allosteric serotonin reuptake inhibitor; CS; Conditioned stimulus; MDD; Major depressive disorder; PCP; Phencyclidine; s.c.; Subcutaneous injec